SKYSTAR BIO-PHARMACEUTICAL COMPANY

News Skystar Bio-Pharmaceutical Company

Equities

SKBI

US8308843007

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2015	Skystar Bio Pharmaceutical Company(NasdaqCM:SKBI) dropped from NASDAQ Composite Index	CI
2014	Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal 2014	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Skystar Bio Pharmaceutical Company(NasdaqCM:SKBI) dropped from NASDAQ Composite Index	20/15/20	CI
Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal 2014	15/14/15	CI
Skystar Bio Mulls Acquisitions	14/14/14	CI
Skystar to Launch Probiotic Supplement for Dairy Cows by End of Fiscal 2014	26/14/26	CI
Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Revenue Guidance for the 2014	15/14/15	CI
Skystar Bio Pharmaceutical Mulls Acquisitions	16/14/16	CI
Skystar Launches Bovine Immunoglobulin G Kits in China	08/14/08	CI
Skystar Bio Pharmaceutical Company Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Reaffirms Revenue Guidance for the Year 2014	16/14/16	CI
Skystar Bio-Pharmaceutical Company Announces Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Revenue Guidance for the Year 2014	01/14/01	CI
Skystar Bio Mulls Acquisitions	04/13/04	CI
Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Reiterates Earnings Guidance for the Fiscal 2013	15/13/15	CI
Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2013; Reiterates Earnings Guidance of 2013	15/13/15	CI
Skystar Bio Pharmaceutical Company Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2013; Reiterates Revenue Guidance for the Year 2013	16/13/16	CI
Skystar Bio Pharmaceutical Company Reports Consolidated Earnings Results for the Year Ended December 31, 2012; Provides Earnings Guidance for the Fiscal 2013	02/13/02	CI
Skystar Bio Pharmaceutical Company Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012; Revises Revenue Guidance for the Fiscal 2012	15/12/15	CI
Skystar Bio Pharmaceutical Company Reports Consolidated Unaudited Earnings Results for the Second Quarter Ended July 30, 2012; Reiterates Fiscal 2012 Earnings Guidance	15/12/15	CI
Skystar Bio Pharmaceutical Company Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2012; Reiterates Earnings Guidance for the Fiscal Year 2012	16/12/16	CI
Skystar Bio Pharmaceutical Company Reports Financial Results for Year Ended December 31, 2011; Provides Revenue Guidance for the Year 2012	02/12/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
SKBI Stock
News Skystar Bio-Pharmaceutical Company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer